» Articles » PMID: 35802912

Oral Cancer Cells Release Vesicles That Cause Pain

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Oral cancer pain is attributed to the release from cancers of mediators that sensitize and activate sensory neurons. Intraplantar injection of conditioned media (CM) from human tongue cancer cell line HSC-3 or OSC-20 evokes nociceptive behavior. By contrast, CM from noncancer cell lines, DOK, and HaCaT are non-nociceptive. Pain mediators are carried by extracellular vesicles (EVs) released from cancer cells. Depletion of EVs from cancer cell line CM reverses mechanical allodynia and thermal hyperalgesia. CM from non-nociceptive cell lines become nociceptive when reconstituted with HSC-3 EVs. Two miRNAs (hsa-miR-21-5p and hsa-miR-221-3p) are identified that are present in increased abundance in EVs from HSC-3 and OSC-20 CM compared to HaCaT CM. The miRNA target genes suggest potential involvement in oral cancer pain of the toll like receptor 7 (TLR7) and 8 (TLR8) pathways, as well as signaling through interleukin 6 cytokine family signal transducer receptor (gp130, encoded by IL6ST) and colony stimulating factor receptor (G-CSFR, encoded by CSF3R), Janus kinase and signal transducer and activator of transcription 3 (JAK/STAT3). These studies confirm the recent discovery of the role of cancer EVs in pain and add to the repertoire of algesic and analgesic cancer pain mediators and pathways that contribute to oral cancer pain.

Citing Articles

The role of cancer cell-released extracellular vesicles: have we become closer to cancer pain treatment?.

Khasabova I, Khasabov S, Simone D Extracell Vesicles Circ Nucl Acids. 2025; 5(4):785-787.

PMID: 39811726 PMC: 11725430. DOI: 10.20517/evcna.2024.89.


miRNA packaging into small extracellular vesicles and implications in pain.

DaCunza J, Wickman J, Ajit S Pain Rep. 2024; 9(6):e1198.

PMID: 39450410 PMC: 11500789. DOI: 10.1097/PR9.0000000000001198.


Measurement of the Association of Pain with Clinical Characteristics in Oral Cancer Patients at Diagnosis and Prior to Cancer Treatment.

Sawicki C, Janal M, Gonzalez S, Wu A, Schmidt B, Albertson D J Pain Res. 2024; 17:501-508.

PMID: 38328017 PMC: 10848821. DOI: 10.2147/JPR.S423318.


Exosome-associated lysophosphatidic acid signaling contributes to cancer pain.

Khasabova I, Khasabov S, Johns M, Juliette J, Zheng A, Morgan H Pain. 2023; 164(12):2684-2695.

PMID: 37278638 PMC: 10652716. DOI: 10.1097/j.pain.0000000000002967.


A pilot study to improve pain phenotyping in head and neck cancer patients.

Ye Y, de Melo Cardoso D, Kayahara G, Bernabe D Front Pain Res (Lausanne). 2023; 4:1146667.

PMID: 37251594 PMC: 10211332. DOI: 10.3389/fpain.2023.1146667.


References
1.
Stosser S, Schweizerhof M, Kuner R . Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions. J Mol Med (Berl). 2010; 89(4):321-9. PMC: 3055988. DOI: 10.1007/s00109-010-0697-z. View

2.
Lee C, Perez F, Wang W, Guan X, Zhao X, Fisher J . Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury. Eur J Pain. 2011; 15(7):669-75. PMC: 3129388. DOI: 10.1016/j.ejpain.2010.11.018. View

3.
Jung H, Phillips B, Patel R, Cohen D, Jakymiw A, Kong W . Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem. 2012; 287(35):29261-72. PMC: 3436145. DOI: 10.1074/jbc.M112.366518. View

4.
Xu P, Van Slambrouck C, Berti-Mattera L, Hall A . Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J Neurosci. 2005; 25(40):9227-35. PMC: 6725762. DOI: 10.1523/JNEUROSCI.3051-05.2005. View

5.
Madeo M, Colbert P, Vermeer D, Lucido C, Cain J, Vichaya E . Cancer exosomes induce tumor innervation. Nat Commun. 2018; 9(1):4284. PMC: 6191452. DOI: 10.1038/s41467-018-06640-0. View